Daniel Faga

Daniel Faga has over two decades of experience in the biotech and pharmaceutical industries. Daniel is currently the Director at AnaptysBio, a position they have held since November 2021.

Previously, Faga served as the Chief Operating Officer at Mirati Therapeutics from January 2020 to November 2021. Prior to that, they were the Chief Business Officer at Spark Therapeutics, Inc. from May 2016 to December 2019.

Faga began their career as an Associate at Merrill Lynch in January 2007 before moving to Centerview Partners in January 2009, where they eventually became Managing Director in December 2016. Daniel also held positions as an Associate at PRTM from January 2002 to December 2005 and PowerAdvocate from January 2001 to December 2002.

Daniel Faga has an MBA from The Wharton School and a B.S. from Cornell University.